Morning Movers 01/20: DEAR, TIBB, LXRX, CTZN, PONE, CREE Higher; VRS, NEXM, AXU, SUPX Lower
Dearborn Bancorp, Inc. (Nasdaq: DEAR) 195% HIGHER; last night reported Q4 EPS of $0.55, which compares to a loss of $3.77 in the same quarter last year. Q4 earnings were sufficient to return the Bank to an "adequately capitalized" category under regulatory guidelines for risk based capital.
TIB Financial (Nasdaq: TIBB) 37.3% HIGHER; the stock moved over the $1 level yesterday for the first time since mid-November. The stock jumped more than 42% yesterday and is continuing higher once again today on very heavy volume.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) 26.4% HIGHER; obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2, lowering the accumulation of glucose in the body and reducing caloric load. LX4211, dosed as a single agent, provided improvements in glycemic control, demonstrating statistically significant benefits in the primary and multiple secondary efficacy endpoints. Click here for the full report.
Citizens First Bancorp (Nasdaq: CTZN) 19.8% HIGHER; upside continues today. The stock approached the $0.50 level yesterday and crossed over this morning. Shares rose 17% yesterday. Momo.
Protection One, Inc. (NASDAQ: PONE) 16.9% HIGHER; today announced that it is commencing a process to explore and evaluate strategic alternatives, including a possible sale of the Company, in order to maximize shareholder value. Protection One has engaged J. P. Morgan to advise the Company's Board of Directors in this process.
Cree Inc. (NASDAQ: CREE) 16.1% HIGHER; reports Q2 EPS of $0.38, ex-items, 8 cents better than the analyst estimate of $0.30. Revenue for the quarter was $199.5 million, which compares to the estimate of $186.81 million. Sees Q3 sales of $215-$225 million, versus the consensus of $189.21 million, on adj-EPS of $0.41-$0.44, which compares to the Street estimate of $0.28.
Hanmi Financial (Nasdaq: HAFC) 16% HIGHER; technicians may be buying the stock once again today as it appears it have held above the important $1 support level last week. After holding this level, the stock jumped 16% from Tuesday to Friday of last week and then 40% yesterday.
TierOne (Nasdaq: TONE) 15.5% HIGHER; rallying again today despite the sharp downside in the broader markets. Shares jumped more than 18% yesterday. Volume remains very heavy today.
Verso Paper (NYSE: VRS) 13.7% LOWER; Credit Suisse downgrades from Outperform to Neutral. Price target $4
Rambus (Nasdaq: RMBS) 12.7% HIGHER; Rambus and Samsung sign a comprehensive pact. Samsung will invest $200 million in Rambus stock. Click here for the full report.
NexMed, Inc. (Nasdaq: NEXM) 12.3% LOWER; announced today that it received a Notice of Non-Compliance as part of the review process from Health Canada for its New Drug Submission for the Vitaros erectile dysfunction treatment filed in February 2008. The deficiencies cited related to the product’s CMC (Chemistry, Manufacturing and Controls). There were no pre-clinical or clinical deficiencies cited in the Notice. The Notice is a routine end-of-review communication from Health Canada when additional information is needed to reach final decision on product approval.
Alexco Resource Corp. (NYSE: AXU) 11.1% LOWER; agrees to sell 7,350, 000 common shares in the Company at a price of C$3.50 per Common Share to raise gross proceeds of C$25,725,000 pursuant to a short form prospectus under the multi-jurisdictional disclosure system. In addition, the Company has granted the Underwriters an over-allotment option to purchase up to that number of additional Common Shares equal to 15% of the Common Shares sold pursuant to the Offering, exercisable at any time up to 30 days from the closing of the Offering.
Supertex Inc. (NASDAQ: SUPX) 11% LOWER; reports Q3 non-GAAP EPS of $0.22, 8 cents better than the analyst estimate of $0.14. Revenue for the quarter was $16.7 million, which compares to the estimate of $17.16 million. The stock was also downgraded to Neutral at Merriman.
Brinker International (NYSE: EAT) 10.8% HIGHER; reports Q2 EPS of $0.29, ex-items, 7 cents better than the analyst estimate of $0.22. Revenue for the quarter was $781.9 million, which compares to the estimate of $774.40 million. Q2 comps down 3.1%.
GenVec (Nasdaq: GNVC) 8.8% HIGHER; traders are buying the stock again today following yesterday's collaboration with Novartis.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
TIB Financial (Nasdaq: TIBB) 37.3% HIGHER; the stock moved over the $1 level yesterday for the first time since mid-November. The stock jumped more than 42% yesterday and is continuing higher once again today on very heavy volume.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) 26.4% HIGHER; obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2, lowering the accumulation of glucose in the body and reducing caloric load. LX4211, dosed as a single agent, provided improvements in glycemic control, demonstrating statistically significant benefits in the primary and multiple secondary efficacy endpoints. Click here for the full report.
Citizens First Bancorp (Nasdaq: CTZN) 19.8% HIGHER; upside continues today. The stock approached the $0.50 level yesterday and crossed over this morning. Shares rose 17% yesterday. Momo.
Protection One, Inc. (NASDAQ: PONE) 16.9% HIGHER; today announced that it is commencing a process to explore and evaluate strategic alternatives, including a possible sale of the Company, in order to maximize shareholder value. Protection One has engaged J. P. Morgan to advise the Company's Board of Directors in this process.
Cree Inc. (NASDAQ: CREE) 16.1% HIGHER; reports Q2 EPS of $0.38, ex-items, 8 cents better than the analyst estimate of $0.30. Revenue for the quarter was $199.5 million, which compares to the estimate of $186.81 million. Sees Q3 sales of $215-$225 million, versus the consensus of $189.21 million, on adj-EPS of $0.41-$0.44, which compares to the Street estimate of $0.28.
Hanmi Financial (Nasdaq: HAFC) 16% HIGHER; technicians may be buying the stock once again today as it appears it have held above the important $1 support level last week. After holding this level, the stock jumped 16% from Tuesday to Friday of last week and then 40% yesterday.
TierOne (Nasdaq: TONE) 15.5% HIGHER; rallying again today despite the sharp downside in the broader markets. Shares jumped more than 18% yesterday. Volume remains very heavy today.
Verso Paper (NYSE: VRS) 13.7% LOWER; Credit Suisse downgrades from Outperform to Neutral. Price target $4
Rambus (Nasdaq: RMBS) 12.7% HIGHER; Rambus and Samsung sign a comprehensive pact. Samsung will invest $200 million in Rambus stock. Click here for the full report.
NexMed, Inc. (Nasdaq: NEXM) 12.3% LOWER; announced today that it received a Notice of Non-Compliance as part of the review process from Health Canada for its New Drug Submission for the Vitaros erectile dysfunction treatment filed in February 2008. The deficiencies cited related to the product’s CMC (Chemistry, Manufacturing and Controls). There were no pre-clinical or clinical deficiencies cited in the Notice. The Notice is a routine end-of-review communication from Health Canada when additional information is needed to reach final decision on product approval.
Alexco Resource Corp. (NYSE: AXU) 11.1% LOWER; agrees to sell 7,350, 000 common shares in the Company at a price of C$3.50 per Common Share to raise gross proceeds of C$25,725,000 pursuant to a short form prospectus under the multi-jurisdictional disclosure system. In addition, the Company has granted the Underwriters an over-allotment option to purchase up to that number of additional Common Shares equal to 15% of the Common Shares sold pursuant to the Offering, exercisable at any time up to 30 days from the closing of the Offering.
Supertex Inc. (NASDAQ: SUPX) 11% LOWER; reports Q3 non-GAAP EPS of $0.22, 8 cents better than the analyst estimate of $0.14. Revenue for the quarter was $16.7 million, which compares to the estimate of $17.16 million. The stock was also downgraded to Neutral at Merriman.
Brinker International (NYSE: EAT) 10.8% HIGHER; reports Q2 EPS of $0.29, ex-items, 7 cents better than the analyst estimate of $0.22. Revenue for the quarter was $781.9 million, which compares to the estimate of $774.40 million. Q2 comps down 3.1%.
GenVec (Nasdaq: GNVC) 8.8% HIGHER; traders are buying the stock again today following yesterday's collaboration with Novartis.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
You May Also Be Interested In
- Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded
- Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
- Trading Radar for 05/25: Mentor Graphics (MENT), Tsakos Energy (TNP) Report
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Merriman Curhan Ford, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
